The Socio-Economic Impact of The Pirbright Institute

Our mission is to be the world's leading innovative centre for preventing and controlling viral diseases of livestock.

We play a crucial role in protecting UK livestock from viruses that have huge socio-economic impact with a unique combination of fundamental research and applied science in diagnostics and control.

Our Impact

Our impact has been captured in a report, The Socio-Economic Impact of The Pirbright Institute, commissioned by Pirbright and carried out by public policy analysts SQW

 

The evaluation shows the Institute:

  • Contributes £50m a year to the UK economy
  • Produced £471m in Gross Value Added (GVA) economic impact over the past decade
  • Supported over 1,000 jobs a year in the UK economy over ten years

 

Two scientists in white lab coats. One is looking down a microscope with purple gloved hands hold a bottle under the microscope. The other person is in the background looking happily at the other

Key Findings

 

Economic Impact

The Institute generated £471 million GVA to the UK economy over the decade to 2024, averaging £52 million annually. ​ It supported approximately 1,088 full-time equivalent (FTE) jobs per year, including highly skilled scientists, technicians, and professional staff. ​ Investments in infrastructure - the Brooksby Building and the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) – has enhanced research capabilities. ​

Disease Control and Prevention

Pirbright plays a critical role in preventing and controlling viral outbreaks through expert advice, diagnostics, and vaccines for diseases like foot-and-mouth disease (FMD), African swine fever (ASF), bluetongue virus (BTV), and avian influenza. Our work on FMD has helped the UK avoid outbreaks since 2007, saving billions in potential losses. Internationally, Pirbright supports disease eradication, such as the global elimination of Rinderpest. ​

Livestock Sector Performance

The Institute’s research and surveillance activities protect livestock health, preventing productivity losses and supporting food security. ​ Our work on viruses like Marek’s disease and peste des petits ruminants (PPR) has improved vaccine development and diagnostic tools, benefiting farmers globally.

Research Excellence

Pirbright published over 800 papers in high-impact journals during the period, contributing to the UK’s leadership in bioscience. It secured over 60 competitive funding awards and collaborated with universities and research institutes worldwide.

Skills Development

The Institute fosters talent through PhD programs, internships, and training courses in viral diseases, biosafety, and high containment engineering. It also supports biosafety and engineering excellence, contributing to the development of the Biorisk Professional Registration Scheme. ​

Global Resilience

Pirbright enhances international capacity to combat viral diseases through partnerships, training, and networks like the International Veterinary Vaccinology Network (IVVN). ​ Its research supports the One Health agenda, addressing the interconnections between animal, human, and environmental health. ​

Image
Impact Infographic

Case Studies

The SQW report includes detailed impact case studies which highlight how Pirbright’s world-class science delivers real-world impact: strengthening biosecurity, improving global food security, advancing vaccines, and supporting the UK’s response to health emergencies.

To view these in summary, and other examples of our impact, visit our impact case studies.

African Swine Fever Virus

African swine fever virus (ASFV) is a deadly disease affecting pigs, with a potential UK outbreak estimated to cost up to £100 million. The Pirbright Institute plays a key role in protecting pig populations and supporting national preparedness by advising Defra and devolved administrations, and guiding farmers and vets on how to respond to outbreaks.

As one of seven WOAH International Reference Laboratories for ASFV, Pirbright strengthens global resilience by providing diagnostics, training, and policy support. Its unique reference collection of over 500 ASFV strains helps improve virus detection, disinfection protocols, and understanding...

Female scientist pipetting

Foot and Mouth Disease

Foot-and-mouth disease (FMD) can cause devastating economic losses, with annual costs in endemic regions reaching up to US$1 billion. The Pirbright Institute plays a vital role in protecting livestock and economies by strengthening national and global preparedness.

As the FAO’s World Reference Laboratory for FMD since 1958, the institute holds the world’s largest archive of FMD samples and provides expert diagnostics, training, and strategic advice. In the UK, it serves as Defra’s National Reference Laboratory, delivering rapid evidence to inform outbreak control strategies and trade decisions...

Person stood presenting in front of seated group. On the tv screen is a slide of someone pipetting with the title biorisk

Leadership in Biosafety

The Pirbright Institute is internationally recognised for its leadership in biosafety, helping to raise global standards in managing biological risks. With around 65% of its resources designated as National Bioscience Research Infrastructure (NBRI) level 1, Pirbright operates high-containment facilities essential for studying serious animal diseases. This expertise supports best practice across the UK and beyond.

Pirbright develops and delivers accredited biosafety training, including online and instructor-led courses. In 2024, it helped launch the Biorisk Professional Registration Scheme (BPRS), approved by the Royal Society of Biology, to support professionals in evidencing and developing skills in biorisk management. Pirbright also provides RSB-accredited training for...

COVID-19 testing equipment at The Pirbright Institute

Contribution to the UK COVID-19 response

The Pirbright Institute played a key role in the UK’s fight against COVID-19, using its expertise in animal coronaviruses to support vaccine development, testing, and virus tracking.

As part of the Oxford-AstraZeneca vaccine team, Pirbright scientists showed that two doses significantly boosted antibody responses in pigs. This evidence helped shape the UK’s two-dose vaccination strategy, which reduced hospitalisations and saved ...

PPRV image

Virus Evolution and Transmission

Understanding how viruses change and spread is key to stopping disease outbreaks before they happen. At The Pirbright Institute, scientists study viruses and the animals they infect, using cutting-edge tools to track how diseases move and evolve. This helps protect livestock, safeguard livelihoods, and prepare for future health threats.

In countries like Cameroon, Nigeria, and Nepal, Pirbright researchers have used simple environmental sampling methods to detect serious livestock diseases such as Foot-and-Mouth Disease (FMD) and Peste des Petits Ruminants (PPR). These low-cost techniques...

Pigs inside stable

One Health Animal Models

The One Health approach recognises the deep connections between human, animal, and environmental health. At The Pirbright Institute, scientists use animal models to better understand and tackle diseases that affect both animals and people.

Pirbright pioneered the use of pigs to study human respiratory viruses, showing their biological similarity to humans. This model has been used to test flu and COVID-19 vaccines. Research using cows led to the development of a bovine respiratory syncytial virus (bRSV) vaccine, which directly supported the approval of a human RSV vaccine—now licensed for older adults and pregnant women, with the potential to save thousands of lives each year. In poultry, Pirbright’s research into viral...